Understanding HPLC Purity and Certificates of Analysis
When purchasing research peptides, laboratories frequently encounter claims such as “99% purity,” “HPLC tested,” or “COA available.”
These phrases sound reassuring, but they should not be accepted without context.
What exactly was measured? Which testing method was used? Does the report correspond to the product batch being sold? Was identity tested separately? Is the laboratory report complete enough to review?
Analytical documentation should help answer these questions.
This guide explains the role of HPLC testing, identity verification, chromatograms, Certificates of Analysis, and batch traceability in research peptide quality evaluation.
What Is HPLC?
High-Performance Liquid Chromatography is an analytical method used to separate and measure components in a sample.
In simplified terms, a prepared sample is introduced into an HPLC system. A liquid mobile phase carries the sample through a column containing a stationary phase.
Different components interact with the system differently. As a result, they travel through the column at different rates and may appear as separate peaks in the final chromatogram.
HPLC is widely used because it can provide useful information about:
- Sample composition
- Relative purity
- Retention time
- Detectable impurities
- Batch consistency
- Degradation patterns
The exact interpretation depends on the method, equipment, sample preparation, and testing conditions.
What Does “99% HPLC Purity” Mean?
A reported HPLC purity value generally represents the relative area of the main detected peak compared with the combined area of relevant detected peaks under the test conditions.
A main peak representing approximately 99% of the measured peak area may support a claim of 99% HPLC purity.
However, the number should not be treated as universal proof of quality.
The result depends on:
- Sample preparation
- Chromatographic method
- Column type
- Mobile phase
- Gradient
- Detection wavelength
- Integration settings
- Impurity detectability
- Instrument calibration
- Analyst procedure
Some compounds may not be detected equally under a particular method. HPLC may also fail to measure substances that do not respond under the selected detection conditions.
Therefore, “99% HPLC purity” means something narrower than “the product is perfect” or “the product is suitable for every possible application.”
Purity Is Not the Same as Identity
This distinction matters.
Purity asks: how much of the detected sample appears to consist of the main component?
Identity asks: is that main component actually the intended peptide?
A sample may produce a dominant HPLC peak and still require additional analysis to support identity.
Identity verification may involve:
- Mass spectrometry
- Sequence-related analysis
- Spectroscopic methods
- Comparison with a reference standard
- Other product-appropriate techniques
HPLC and mass spectrometry are often discussed together because they answer different but complementary questions.
HPLC may support purity evaluation, while mass spectrometry may support confirmation of expected molecular mass.
A responsible supplier should avoid presenting one test as proof of every product attribute.
What Is a Chromatogram?
A chromatogram is the graphical output produced during chromatographic analysis.
The horizontal axis commonly represents retention time. The vertical axis represents detector response.
Each peak may correspond to a component detected in the sample.
The largest peak is often associated with the primary component, while smaller peaks may represent impurities, related substances, degradation products, or analytical artifacts.
A chromatogram may display:
- Peak retention times
- Peak heights
- Peak areas
- Relative area percentages
- Baseline
- Analysis duration
- Instrument information
- Sample identification
A chromatogram should not be evaluated solely by how clean or professional it looks. The information must be connected to the correct sample, method, and batch.
What Is Retention Time?
Retention time is the period between sample injection and detection of a particular component.
Under consistent conditions, retention time may help compare an unknown sample with a known reference or expected analytical profile.
However, retention time alone does not definitively establish identity. Changes in method conditions can alter retention behavior.
Factors influencing retention time may include:
- Column chemistry
- Mobile-phase composition
- Flow rate
- Temperature
- Gradient
- Sample concentration
- Instrument performance
Retention time should be interpreted as one part of a broader analytical evaluation.
Understanding Peak Area
Peak area represents the integrated detector response associated with a chromatographic peak.
Relative peak-area calculations may be used to estimate the proportion of the primary component compared with other detected components.
For example, the main peak area may be divided by the total relevant peak area and expressed as a percentage.
This calculation may support a purity result, but its reliability depends on appropriate peak detection and integration.
Incorrect baseline selection, omitted peaks, or inconsistent integration settings can influence the reported percentage.
For that reason, a purity number should ideally be supported by the complete chromatogram and testing information rather than shown as an isolated marketing badge.
Common Sources of Peptide Impurities
Peptide impurities may arise during manufacturing, purification, storage, or handling.
Potential sources include:
Incomplete Reactions
An amino acid may fail to couple correctly during synthesis.
Truncated Sequences
The resulting material may contain shorter peptide chains.
Deletion Sequences
One or more amino acids may be missing from the intended sequence.
Side Reactions
Chemical reactions may produce related but unintended compounds.
Oxidation
Certain amino-acid residues may be vulnerable to oxidative changes.
Deamidation or Other Degradation
Environmental conditions may cause structural modification over time.
Residual Processing Materials
Trace substances may remain from synthesis or purification.
Storage Damage
Heat, moisture, light, or repeated exposure may reduce stability.
Understanding the impurity profile may be important for highly sensitive applications.
What Is a Certificate of Analysis?
A Certificate of Analysis is a document summarizing testing and specification information for a product or batch.
For research peptides, a COA may include:
- Product name
- Sequence
- Batch number
- Lot number
- Date of manufacture
- Test date
- Purity result
- Analytical method
- Molecular formula
- Molecular weight
- Appearance
- Storage conditions
- HPLC chromatogram
- Mass spectrum
- Testing laboratory details
- Approval or review information
Not every COA contains all these fields. The appropriate content depends on the product and the supplier’s quality system.
The document should still provide enough information to identify the tested material and understand the reported result.
Why the Batch Number Matters
The batch or lot number connects the product to its manufacturing and testing records.
Suppose a website displays a COA for Batch A, but the customer receives Batch B. The displayed report may not describe the supplied product.
This does not automatically mean Batch B is defective. It means the documentation is not properly aligned.
Strong traceability requires consistency across:
- Product label
- COA
- Inventory record
- Order record
- Testing report
- Internal batch documentation
Researchers should review the batch number when receiving a product and retain relevant documentation in their laboratory records.
Generic COAs Versus Batch-Specific COAs
A generic COA may present a standard specification or an example report. It can help researchers understand what information is normally provided.
However, it does not replace a batch-specific report.
A batch-specific COA relates to a clearly identified production lot and contains results associated with that material.
Suppliers should label sample reports honestly. Calling an example document a batch-specific COA is misleading.
For current inventory, the best practice is to make the relevant batch report accessible through the product page, order documentation, or customer support process.
What Does Third-Party Testing Mean?
Third-party testing means that an external analytical laboratory evaluates a sample rather than the supplier relying exclusively on internal analysis.
Independent testing may strengthen confidence by adding separation between the seller and the testing process.
However, the phrase alone is not enough.
Researchers should ask:
- Which product was tested?
- Which batch was tested?
- Which method was used?
- When was the testing completed?
- Is the laboratory identified?
- Is the complete report available?
- Does the report match current inventory?
A badge saying “third-party tested” without supporting documentation is still just a badge.
Internal Testing Versus Independent Testing
Both internal and independent testing can be valuable.
Internal testing may support:
- Rapid quality review
- Process monitoring
- Batch comparison
- Manufacturing decisions
- Routine release procedures
Independent testing may support:
- External verification
- Additional credibility
- Confirmation of selected results
- Customer transparency
The quality of the test depends on the method, laboratory competence, sample handling, and documentation—not simply whether it was conducted internally or externally.
How to Review a Peptide COA
Researchers can use a structured review process.
Step 1: Confirm the Product Name
The name on the COA should match the ordered compound.
Step 2: Match the Batch Number
Check that the batch listed on the COA corresponds to the received product.
Step 3: Review the Testing Date
Determine whether the report relates to the current production period.
Step 4: Identify the Testing Method
Look for HPLC, mass spectrometry, or another stated analytical method.
Step 5: Review the Purity Result
Confirm whether the result meets the laboratory’s project requirements.
Step 6: Examine the Chromatogram
Check that the report includes the relevant main peak, smaller peaks, retention times, and area calculations.
Step 7: Review Identity Information
Compare expected and observed molecular information when provided.
Step 8: Check Storage Instructions
Make sure the storage requirements are clear and practical.
Step 9: Retain the Documentation
Store the COA with internal inventory and project records.
This process does not replace the laboratory’s own qualification procedures, but it helps identify obvious documentation gaps.
Red Flags in Analytical Documentation
Researchers should be cautious when they encounter:
- No batch number
- Blurry or unreadable reports
- Cropped chromatograms
- Missing product identification
- Reused documents across unrelated products
- A report that does not match the received batch
- Purity claims without a stated method
- Altered laboratory details
- Inconsistent dates
- No connection between mass and identity
- Claims that HPLC proves sterility or human safety
A supplier should be able to explain the scope and limitations of its testing.
Why Transparency Matters
Analytical transparency supports informed purchasing and stronger experimental planning.
It allows researchers to evaluate whether:
- The material meets project specifications
- The purity level is adequate
- Identity is reasonably supported
- The batch is traceable
- Storage conditions are suitable
- Additional in-house qualification is required
Transparent documentation also holds suppliers accountable.
A supplier should not expect customers to rely entirely on slogans, product images, or broad assurances.
The Johnson Peptides Quality Approach
Johnson Peptides focuses on research products supported by analytical testing and clear documentation.
Applicable batches are evaluated for identity and purity before release. Batch-specific Certificates of Analysis are available to provide relevant analytical information.
Testing details may vary by product and batch. Researchers should review the documentation associated with the specific product they intend to purchase.
All products are supplied exclusively for laboratory research and analytical use.
HPLC Does Not Establish Human Safety
This point needs to be blunt because many websites muddy the water.
An HPLC purity result does not establish that a product is:
- Sterile
- Safe for injection
- Safe for consumption
- Clinically effective
- Approved as a medicine
- Suitable for veterinary use
- Free from every possible contaminant
HPLC is an analytical tool. It should not be stretched into a medical or safety claim.
Research products must remain within their stated research context.
Final Thoughts
HPLC purity and Certificates of Analysis are important parts of research peptide evaluation, but the numbers need context.
Researchers should look for complete, batch-specific documentation and understand the difference between purity, identity, sterility, and safety.
A responsible supplier should provide clear answers to three basic questions:
- What was tested?
- How was it tested?
- Which batch does the result represent?
When those answers are documented properly, researchers can make more informed purchasing and quality-control decisions.